Showing 73 to 84 of 365 results


Biden Diagnosed with Aggressive Prostate Cancer
Former US President Joe Biden, 82, has been diagnosed with an aggressive, hormone-sensitive prostate cancer with bone metastasis, prompting concerns about his health and future activities; his Gleason score is 9.
Biden Diagnosed with Aggressive Prostate Cancer
Former US President Joe Biden, 82, has been diagnosed with an aggressive, hormone-sensitive prostate cancer with bone metastasis, prompting concerns about his health and future activities; his Gleason score is 9.
Progress
40% Bias Score


Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis
Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.
Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis
Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.
Progress
36% Bias Score


GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...
GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...
Progress
40% Bias Score


\"German Skin Cancer Treatments Surge 88 Percent in Two Decades\"\
Hospital treatments for skin cancer in Germany increased by 88 percent between 2003 and 2023, reaching 116,900 cases, driven by an aging population, improved early detection, and the long-term effects of past sun exposure.
\"German Skin Cancer Treatments Surge 88 Percent in Two Decades\"\
Hospital treatments for skin cancer in Germany increased by 88 percent between 2003 and 2023, reaching 116,900 cases, driven by an aging population, improved early detection, and the long-term effects of past sun exposure.
Progress
32% Bias Score


Cancer Diagnoses Surge Among Young Dutch Adults
A new report from the Integraal Kankercentrum Nederland (IKNL) reveals a significant increase in cancer diagnoses among young adults (18-39) in the Netherlands, with women being diagnosed 1.5 times more often than men; the most common cancers for young women are breast, cervical and melanoma, while ...
Cancer Diagnoses Surge Among Young Dutch Adults
A new report from the Integraal Kankercentrum Nederland (IKNL) reveals a significant increase in cancer diagnoses among young adults (18-39) in the Netherlands, with women being diagnosed 1.5 times more often than men; the most common cancers for young women are breast, cervical and melanoma, while ...
Progress
24% Bias Score


Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Progress
32% Bias Score

Light Physical Activity Significantly Reduces Cancer Risk: Oxford Study
A new Oxford University study using activity tracker data from 85,394 UK Biobank participants found that even light physical activity, such as walking 7,000 steps daily, reduces cancer risk by 11% compared to 5,000 steps, reaching 16% reduction at 9,000 steps, highlighting the importance of daily mo...

Light Physical Activity Significantly Reduces Cancer Risk: Oxford Study
A new Oxford University study using activity tracker data from 85,394 UK Biobank participants found that even light physical activity, such as walking 7,000 steps daily, reduces cancer risk by 11% compared to 5,000 steps, reaching 16% reduction at 9,000 steps, highlighting the importance of daily mo...
Progress
44% Bias Score

King Charles Reports Positive Cancer Treatment Progress Amidst Family Tensions
King Charles III, 76, reported positive progress in his cancer treatment, stating he's on the 'better side' of his journey, during a visit to Bradford celebrating its UK City of Culture status; this comes amidst Prince Harry's public comments expressing uncertainty about the King's lifespan due to a...

King Charles Reports Positive Cancer Treatment Progress Amidst Family Tensions
King Charles III, 76, reported positive progress in his cancer treatment, stating he's on the 'better side' of his journey, during a visit to Bradford celebrating its UK City of Culture status; this comes amidst Prince Harry's public comments expressing uncertainty about the King's lifespan due to a...
Progress
60% Bias Score

GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...

GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...
Progress
20% Bias Score

Andalusian Health Service to Pay €250,000 for Cancer Misdiagnosis
A Seville hospital wrongly diagnosed a 39-year-old woman with sarcoma in 2017, leading to unnecessary surgery and experimental treatment; the Andalusian High Court ordered €250,000 in compensation for permanent harm caused by medical negligence.

Andalusian Health Service to Pay €250,000 for Cancer Misdiagnosis
A Seville hospital wrongly diagnosed a 39-year-old woman with sarcoma in 2017, leading to unnecessary surgery and experimental treatment; the Andalusian High Court ordered €250,000 in compensation for permanent harm caused by medical negligence.
Progress
52% Bias Score

Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.

Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.
Progress
48% Bias Score

Annual Blood Tests Show Promise in Early Cancer Detection
Annual multi-cancer blood tests could prevent up to 49% of late-stage diagnoses, reducing deaths by 21% within five years, according to a study using a new test trialed by the NHS involving 8,000 patients, detecting up to 12 common cancers, and using AI to pinpoint cancer location.

Annual Blood Tests Show Promise in Early Cancer Detection
Annual multi-cancer blood tests could prevent up to 49% of late-stage diagnoses, reducing deaths by 21% within five years, according to a study using a new test trialed by the NHS involving 8,000 patients, detecting up to 12 common cancers, and using AI to pinpoint cancer location.
Progress
40% Bias Score
Showing 73 to 84 of 365 results